Orion Oyj
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, other European countries, North America, and internationally. It provides prescription drugs and self-care products, including Nubeqa for the treatment of prostate cancer; dexdor and Precedex for intensive care sedative; Stalevo and Comtess/Comtan for Parkinson's disease; Simdax for acute decompensated heart failure; and Fareston for breast cancer, as well as Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler for the treatment of asthma and chronic obstructive pulmonary disease. The company also offers veterinary drugs; and APIs for generic and proprietary drugs, as well as provides contract manufacturing services. In addition, it markets and sells veterinary drugs manufactured by other international companies. The company has a collaboration with Nanoform to apply Nanoform's CESS technology to new chemical entities. It serves various healthcare service providers and professionals, such as specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories. Orion Oyj is headquartered in Espoo, Finland. Show More...
-
Website http://www.orion.fi
-
Sector Healthcare
-
Industry Drug Manufacturers-General
-
Last Quote 35.39 EUR
-
Last Updated 25-04-2024
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share EUR 1.31 1.49 1.47 1.46 1.5 1.48 1.77 1.61 2.35 1.43 1.61 Dividends EUR 1.0 1.2 1.3 1.3 1.25 1.3 1.3 1.35 1.45 1.5 Payout Ratio % * 78.1 83.9 86.7 94.2 85.6 87.3 76.0 86.5 100.0 101.4 Shares Mil 141.0 141.0 141.0 141.0 141.0 141.0 141.0 141.0 141.0 141.0 141.0 Book Value Per Share * EUR 3.05 3.22 3.33 3.4 3.66 3.59 4.19 4.23 5.24 5.07 5.99 Free Cash Flow Per Share * EUR 1.15 1.19 1.24 0.86 1.79 1.49 1.44 1.24 1.18 1.48 Return on Assets % 25.08 27.48 25.85 22.71 21.34 20.32 23.6 21.34 30.0 18.37 18.42 Financial Leverage (Average) 1.6 1.56 1.64 1.91 1.95 1.76 1.66 1.55 1.48 1.33 1.47 Return on Equity % 40.75 43.31 41.32 40.23 41.08 37.52 40.29 34.22 45.47 25.82 31.05 Return on Invested Capital % 32.4 36.06 34.0 29.45 28.3 27.7 32.05 28.24 38.01 23.56 25.65 Interest Coverage 43.81 48.0 108.42 67.0 49.69 51.44 68.59 64.67 56.2 110.04 134.48 Current Ratio 3.01 2.71 2.94 3.19 3.04 2.89 3.0 3.45 2.32 3.2 3.49 Quick Ratio 2.11 1.82 1.88 2.18 2.16 1.99 1.98 2.16 1.57 1.93 2.5 Debt/Equity 0.19 0.13 0.21 0.45 0.41 0.3 0.23 0.22 0.010 0.13